Category: Diseases & Conditions
Global Diseases & Conditions
-
Healthcare Information Software
... by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals Application, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$22.7 Billion by ... Read More
-
Heavy-Duty Pumps
... at a CAGR of 4.8% over the analysis period 2023-2030. Centrifugal Pumps, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.1 Billion by the end of ... Read More
-
Hydraulic Dosing Pumps
... by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Diaphragm Pumps, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$650.7 Million by ... Read More
-
Nucleating and Clarifying Agents
... reach US$5.5 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Packaging Application, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach ... Read More
-
Online Home Rental Services
... reach US$65.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2023-2030. Flats, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$36.3 ... Read More
-
Clinical Rollators
... at a CAGR of 5.0% over the analysis period 2023-2030. 4-Wheeler Rollators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$262.0 Million by the end of ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More
-
Hazmat Suits
... at a CAGR of 4.7% over the analysis period 2023-2030. Infection Control & Bio-Hazard Application, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.6 Billion by ... Read More
-
High Pressure Pumps
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Dynamic Pumps, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.0 Billion by ... Read More
-
Needle-Free IV Connectors
... by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Positive Fluid Displacement Connectors, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$997.5 ... Read More
-
Automotive Electronics Conformal Coatings
... reach US$1.4 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Acrylic Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach ... Read More
-
Hybrid and Electric Vehicle Fuses
... is expected to reach US$10.3 Billion by 2030, growing at a CAGR of 24.4% over the analysis period 2023-2030. Hybrid Electric Vehicles (HEVs) Application, one of the segments analyzed in the report, is expected to ... Read More
-
Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, Sublingual, and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034 Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, ... Read More
-
Digital Diabetes Management
... at a CAGR of 18.6% over the analysis period 2023-2030. Digital Diabetes Management Devices, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$46.7 Billion by the ... Read More
-
Insulin Storage Devices
... at a CAGR of 7.3% over the analysis period 2023-2030. Battery Operated Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$996.0 Million by the end ... Read More
-
Walnut
... 2.8% over the analysis period 2023-2030. Black Walnuts, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$570.1 Million by the end of the analysis period. Growth ... Read More
-
Women's Health Rehabilitation Products
... 2030, growing at a CAGR of 1.2% over the analysis period 2023-2030. Orthopedic Rehabilitation Products, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$731.9 Million by ... Read More
-
Intraoperative Radiation Therapy
... at a CAGR of 5.8% over the analysis period 2023-2030. Systems / Accelerators, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$22.9 Million by the end ... Read More
-
Cold Pressed Juices
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Mixed Fruit & Vegetable Juices, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
-
Color Detection Sensors
... by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Color Sensors, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$1.3 Billion by ... Read More
-
Complex-Oxide Nanomaterials
... at a CAGR of 12.0% over the analysis period 2023-2030. Lithium Titanate, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$1.8 Billion by the end of ... Read More
-
Hemophilia Drugs
... at a CAGR of 5.4% over the analysis period 2023-2030. Hemophilia A Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$21.3 Billion by the end ... Read More
-
Ocular Implants
... at a CAGR of 4.3% over the analysis period 2023-2030. Glaucoma Implants, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$6.5 Billion by the end of ... Read More
-
Oncology Information Systems
... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.5 Billion by ... Read More
-
Immunotherapy Drugs
... at a CAGR of 9.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$254.4 Billion by the end of ... Read More
Research Assistance
